Drug Approval | September 04, 2025
Lupin receives FDA approval for Risperidone LAI with 180-day CGT exclusivity
This is Lupin's first product using proprietary Nanomi's technology and has a 180-day CGT exclusivity
This is Lupin's first product using proprietary Nanomi's technology and has a 180-day CGT exclusivity
He will be leading the design and execution of transformative strategies that harness the power of AI and automation, drive process optimization, and ignite digital innovation
Fortis will assume complete operational and financial control, allowing it to consolidate the hospital's performance within its network
The hospital opens with 300 operational beds, including 100+ ICU beds and 5 advanced operating theatres
Enters the high growth vitamins, minerals and supplements segment for adults, paediatrics, and animal health
Merger is expected to streamline operations and provide unified management focus, driving efficiency and strategic alignment
The FDA also expanded Repatha’s use as monotherapy to include patients with homozygous familial hypercholesterolemia
New manufacturing facility in Mebane to produce at least 40 million laboratory pipette tips per week
The first pillar is advanced manufacturing, focused on upgrading existing CDMO
Terufusion Advanced Infusion Systems combine a smart syringe pump, smart infusion pump, and pump monitoring system software for precise and efficient drug administration
Subscribe To Our Newsletter & Stay Updated
